AbCellera Results Presentation Deck

Q1 2021 BUSINESS UPDATE. HIGHLIGHTS 16 NEW PROGRAMS UNDER CONTRACT 119 CUMULATIVE PROGRAMS UNDER CONTRACT $203M IN REVENUE Expanded existing & new partnerships Diversified program portfolio Positioned for growth with strong liquidity AbCellera 16 new programs under contract (PUCS) across one existing partner and two new partners, including the expansion of a single target deal with Gilead Sciences into a new multi-year, multi-target agreement. Intention to generate a portfolio of hundreds of royalty positions, forging new partnerships and expanding our work with existing ones. $680 million in cash and $190 million in accrued accounts receivable at quarter end. COPYRIGHT ABCELLERA 5

View entire presentation